Health experts highlight how this highly contagious disease affects vulnerable populations and share insights on prevention ...

Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and ...

(WKRG) — More RSV cases are being reported in Mobile. It’s something you may not think much about unless you have children, ...

Merck's (MRK) monoclonal antibody clesrovimab shows cuts RSV infections by 60% in infants, with a strong safety profile. Read ...

RSV is a highly contagious virus affecting the respiratory system, especially dangerous for infants, young children, and ...

A team of researchers has identified signs tied to more severe cases of respiratory syncytial virus (RSV) in children.

GSK presents positive data for AREXVY, its respiratory syncytial virus (RSV) vaccine, indicating protection over three RSV ...

Rising cases of severe respiratory syncytial virus (RSV) in kids show new warning signs, highlighting the need for increased ...

Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and ...

RSV is a highly contagious virus affecting the respiratory system, especially dangerous for infants, young children, and pregnant women. It leads to symptoms ranging from mild colds to severe ...

Merck announces positive results from Phase 2b/3 and interim Phase 3 trials of a monoclonal antibody designed to protect infants from RSV.